SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures.
about
Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short formResponsiveness of the short-form health survey and the Parkinson's disease questionnaire in patients with Parkinson's diseaseHealth-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veteransA novel conceptual framework for balance training in Parkinson's disease-study protocol for a randomised controlled trial.Patients' and caregivers' experiences of the impact of Parkinson's disease on health statusTiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation.Health-related quality of life of australians with Parkinson disease: a comparison with international studies.DTI correlates of distinct cognitive impairments in Parkinson's diseaseAssociations of sleep disturbance symptoms with health-related quality of life in Parkinson's diseaseHealth-related quality-of-life scales in Parkinson's disease: critique and recommendations.Health-related quality of life as a predictor of recurrent falling in Parkinson's disease: 1-year follow-up study.Quality of life in patients with progressive supranuclear palsy: one-year follow-up.Uncovering indicators of the international classification of functioning, disability, and health from the 39-item Parkinson's disease questionnaire.Health-related quality of life in Parkinson's disease patients in northeastern Sicily, Italy: (An ecological perspective).Conceptualizing and prioritizing clinical trial outcomes from the perspectives of people with Parkinson's disease versus health care professionals: a concept mapping study.Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample.Psychometric Evaluation of the Parkinson's Disease Activities of Daily Living Scale.L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.Validity, Reliability, and Insights from Applying the McGill Quality of Life Questionnaire to People Living with Parkinson's Disease (MQoL-PD).A longitudinal study of the SF-36 version 2 in Friedreich ataxia.Quality-of-life of patients with Parkinson's disease.Concordance between severity of disease, prevalence of nonmotor symptoms, patient-reported quality of life and disability and use of medication in Parkinson's disease.Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis
P2860
Q30581735-DE5D34F6-598A-4A45-B7F5-48712E97A586Q33577007-0E22AE6C-3DB9-4E1A-A5F3-1BDAD927651BQ34128695-BE0C7499-FED5-4EA5-B691-7EE4DA345933Q34423006-533B036B-8749-49B3-99C1-BA40BAF9F265Q35052613-92EBECA4-D7EA-4573-88E5-12936E57DE43Q36206178-8EC273E7-5913-472B-A296-43B25DC91A6AQ36359405-FD8C63B8-402E-42E8-826A-302A6EFE8653Q36875720-F26C0C93-0DA9-4184-AC7E-3AA0A7004C82Q37651800-B96CA288-5C4B-4615-B615-90F49743319DQ37898591-061BD4B2-2232-454C-A207-7807551F2ADDQ40118034-7F1498A1-07A2-4A60-83DA-41340FF2AAA9Q41674282-D1955542-8537-468F-B1AA-F87AE8F9070BQ42408135-228E38B7-581E-4373-B211-7FC971364C99Q42844633-EB8E4FCD-967E-40BA-9AED-50119F7A8BF8Q43747340-5EDB5911-1462-403D-B892-01236FA505D2Q46398612-C8FB06D9-5EFF-411F-A45C-308C51E23624Q47106020-3055D4B5-E076-4D10-B566-351692ACB1C2Q47615634-75776B81-0BEB-4B83-B225-C542E64C3907Q47832327-2309FCCA-80CC-47A2-B90F-4D2F5EBA4473Q47927277-0E31A669-1679-41EA-8866-E4B2352C6EFBQ48076035-45F083AC-AAF5-4052-B6BC-5BCCD59ED33DQ48549458-7BD64B43-749E-4D94-9A93-E61E7DF0DAC2Q59130137-87FC9E36-CCB9-46B7-8A1A-FC8ACE0B5118
P2860
SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
SF-36 includes less Parkinson ...... ated quality of life measures.
@en
SF-36 includes less Parkinson Disease
@nl
type
label
SF-36 includes less Parkinson ...... ated quality of life measures.
@en
SF-36 includes less Parkinson Disease
@nl
prefLabel
SF-36 includes less Parkinson ...... ated quality of life measures.
@en
SF-36 includes less Parkinson Disease
@nl
P2093
P2860
P1476
SF-36 includes less Parkinson ...... ated quality of life measures.
@en
P2093
Barbara G Vickrey
Carlos A Brown
Eric M Cheng
Ron D Hays
Stefanie D Vassar
P2860
P2888
P304
P356
10.1007/S11136-009-9530-Y
P577
2009-08-28T00:00:00Z